PRQR - ProQR Therapeutics N.V.

QQQ $ 454.82 $ 1.73 (0.38 %)

DIA $ 398.57 $ -2.04 (-0.52 %)

SPY $ 530.36 $ 0.37 (0.07 %)

TLT $ 91.26 $ -1.31 (-1.43 %)

GLD $ 225.37 $ 2.27 (1.05 %)

Previous Close

$ 1.84

Open

$ 1.87

Bid

$ 1.81 x 103

Ask

$ 0.00 x 0

Day's Range

$ 1.81 - $ 1.88

52 Week Range

$ 1.11 - $ 3.29

Volume

112,819

Average Volume

Market Cap

149.69M

Beta (5Y Monthly)

$ 1.01

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Chardan Capital Maintains Buy on ProQR The...
05/10/2024 14:14:00

Chardan Capital analyst Keay Nakae maintains ProQR Therapeutics (NASDAQ:PRQR) with a Buy and maintains $2.5 price target.

HC Wainwright & Co. Reiterates Buy on ProQ...
05/10/2024 12:21:51

HC Wainwright & Co. analyst Andrew Fein reiterates ProQR Therapeutics (NASDAQ:PRQR) with a Buy and maintains $5 price ta...

ProQR Therapeutics' Cash And Cash Equivale...
05/09/2024 11:58:46

ProQR Therapeutics Q1 2024 GAAP EPS €(0.09...
05/09/2024 11:56:56

ProQR Gives Preclinical Proof Of Concept D...
05/08/2024 12:27:33

ProQR scientists report for the first time in the ADAR RNA editing field in vivo proof of target engagement (RNA editing) leadi...

ProQR Therapeutics To Present On Axiomer R...
04/22/2024 20:39:07

ProQR Therapeutics Says It Achieved Succes...
04/19/2024 11:06:57

The company announced it has again successfully defended against opposition filed against a key patent for its ADAR-mediated RN...

HC Wainwright & Co. Reiterates Buy on ProQ...
03/14/2024 11:16:31

HC Wainwright & Co. analyst Andrew Fein reiterates ProQR Therapeutics (NASDAQ:PRQR) with a Buy and maintains $5 price ta...

Chardan Capital Maintains Buy on ProQR The...
03/14/2024 10:27:32

Chardan Capital analyst Keay Nakae maintains ProQR Therapeutics (NASDAQ:PRQR) with a Buy and raises the price target from $2...

ProQR Therapeutics' 2023 Cash And Cash Equ...
03/13/2024 11:10:36

ProQR Therapeutics FY EPS $(0.38) Up From ...
03/13/2024 11:09:21

ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.38) per share. This is a 61.09 percent increase over losses o...

ProQR Says Japanese Axiomer Patent Upheld ...
02/15/2024 12:20:34

ProQR Therapeutics Highlights New Platform...
01/19/2024 12:12:09

ProQR Highlights New Platform Data from Pr...
01/19/2024 12:05:59

Platform demonstrates robust in vivo editing capabilities reporting up to 70% editing of ACTB in the liver of non-human prima...

why-keycorp-shares-are-trading-lower-by-over-5-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why KeyCorp Shares Are Trading Lower By Ov...
01/18/2024 18:08:48

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results...

why-airspan-networks-shares-are-trading-higher-by-over-380-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Airspan Networks Shares Are Trading Hi...
01/17/2024 18:12:57

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announ...

ProQR Therapeutics And Rett Syndrome Resea...
01/05/2024 12:14:58

ProQR Therapeutics Divested Its Ophthalmic...
12/08/2023 12:33:04

US Stocks Lower; Dow Falls Over 50 Points
11/27/2023 14:46:30

U.S. stocks traded lower this morning, with the Dow Jones index falling over 50 points on Monday. Following the market opening...

Bluebird Bio To Rally Around 267%? Here Ar...
11/08/2023 12:30:46

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...